Shares of agricultural bioscience company Yield10 Bioscience, Inc. (YTEN) risen 16.22% in an extended trading session on Thursday.
That came after the price of YTEN moved down by -$1.24 or -6.42% during the normal trading session on Thursday to settle at $18.06. The trading volume of Yield10 Bioscience Inc. (YTEN) stock remained 79753.0 shares, which was low, compared to its average daily volume of 270.18K shares. The rise in after-hour trading is likely to be the recovery the stock price has been making after going through a decline in the regular session.
What does the company do?
Yield10 Bioscience, Inc. is an agricultural bioscience organization that produces seed technologies that are associated with sustainable agriculture, social responsibility, and biodiversity patterns.
- In order to grow enhanced Camelina varieties to produce patented products and to produce high-value seed traits for the agriculture and food industries, the company uses its “Trait Factory,” a distinct trait gene discovery platform including the “GRAIN” big data mining trait gene discovery method, as well as the Camelina oilseed “Fast Field Testing” scheme.
- The Company’s goals are to develop and market a high-value crop products business efficiently based on superior Camelina varieties for the production of feedstock oils, nutritional oils, and bioplastics from PHA.
- Yield10 is following a cooperation strategy with major agricultural firms as a road to the commercial exploitation of innovative features to push new characteristics into the production of canola, soybeans, maize, and other commercial crops.
Earlier this month, Yield10 Bioscience closed an underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share. A total of about $12.7 million was realized before deduction of commissions, underwriting discounts, and other costs affiliated to the offering. In the offering, institutional and retail investors as well as existing investors, including Jack W. Schuler, participated. As single book-running manager, Maxim Group LLC handled all issuances in the public offering.